Invention Grant
- Patent Title: Quinazoline analogs as receptor tyrosine kinase inhibitors
-
Application No.: US15606928Application Date: 2017-05-26
-
Publication No.: US10221194B2Publication Date: 2019-03-05
- Inventor: Eli Wallace , Joseph Lyssikatos , George Topalov , Alexandre Buckmelter , Qian Zhao
- Applicant: ARRAY BIOPHARMA INC.
- Applicant Address: US CO Boulder
- Assignee: Array BioPharma Inc.
- Current Assignee: Array BioPharma Inc.
- Current Assignee Address: US CO Boulder
- Agency: Viksnins Harris Padys Malen LLP
- Agent Corey M. Williams
- Main IPC: C07D239/94
- IPC: C07D239/94 ; C07D498/10 ; C04B35/632 ; C07D401/12 ; C07D413/12 ; C07D413/14 ; C07D417/14 ; C07D498/04 ; A61K31/517 ; A61P35/04
Abstract:
The invention relates to compounds of Formula 11, and to pharmaceutically acceptable acid addition salts thereof, wherein R1—R3, R6, and X have any of the values defined in the specification. The compounds are suitable as synthetic intermediates for preparing imaging tools.
Public/Granted literature
- US20170260202A1 QUINAZOLINE ANALOGS AS RECEPTOR TYROSINE KINASE INHIBITORS Public/Granted day:2017-09-14
Information query
